Inceptor Bio to Present at ASGCT in Baltimore

Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced two poster presentations at the ASGCT in Baltimore (AACR ANNUAL MEETING 2024)

Poster Presentation #819:
Presenter: Warren Anderson, Ph.D.
Title: OUTLASTTM CAR-T Cells Exhibit Superior Effector Function Against Solid Tumors
Date: May 8th, 2024
Time: 5:30pm EST

Poster Presentation #1805:
Presenter: Anastasya Birger, Ph.D.
Title: Novel costimulatory domain improves CAR-Monocyte activity aganinst tumors
Date: May 10th, 2024
Time: 12pm EST

About Inceptor Bio

Founded in 2020, Inceptor Bio is a biotechnology company strategically advancing a pipeline of diversified cell therapies in oncology. Inceptor is developing CAR-T, CAR-M, & CAR-NK products engineered for optimal efficacy against solid tumors. Additional information about Inceptor Bio is available at www.inceptor.bio.